Xeris (Nasdaq: XERS) is a progress-oriented biopharmaceutical company dedicated to improving upon patients’ lives by acquiring and commercializing differentiated and progressive products throughout a range of therapies. Xeris has a few commercially readily available items: Gvoke®, a Completely ready-to-use liquid glucagon with the therapy of cri… Read More